Skip to main content
. 2020 May 28;10(2):153–165. doi: 10.1002/cpdd.817

Figure 2.

Figure 2

Mean (SD) plasma lemborexant concentration‐time curves for healthy adult and elderly subjects who received lemborexant for 14 days in Study 002 (A,C) and healthy Japanese and white subjects who received lemborexant for 14 days in Study 003 (B,D).